PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26511508-7	2015	Using in silico modeling and drug-target interaction studies, we identified that the U.S. Food and Drug Administration-approved thrombin inhibitor argatroban is a Morf4l1 antagonist.	argatroban	147-157	mortality factor 4 like 1	Mus musculus	163-170	
32694659-6	2020	Blocking of MRG15 by CRISPR targeting or by the FDA-approved drug argatroban, which is an antagonist to MRG15, attenuates liver steatosis.	argatroban	66-76	mortality factor 4 like 1	Mus musculus	12-17	
32694659-6	2020	Blocking of MRG15 by CRISPR targeting or by the FDA-approved drug argatroban, which is an antagonist to MRG15, attenuates liver steatosis.	argatroban	66-76	mortality factor 4 like 1	Mus musculus	104-109	
26511508-8	2015	Argatroban inhibited Morf4l1-dependent histone acetylation, reduced its cytotoxicity, and improved survival of mice with experimental lung injury at doses that had no anticoagulant activity.	argatroban	0-10	mortality factor 4 like 1	Mus musculus	21-28